The following drugs and devices are in question and might be considered as a financially recoverable case. Please call Robert John & Associates P.C. ("RJA") if you feel you have suffered harm or damage from any of these products.
Stevens-Johnson syndrome is an immune complex hypersensitivity reaction that can be caused from an infection or immune response to drugs. It is a severe expression of a simple rash known as erythema multiforme. SJS is also known as erythema multiforme major. It affects all ages and genders including pediatric populations. The most severe form of SJS is toxic epidermal necrolysis (TENS). SJS occurs twice as often in men as in women. Most cases of SJS appear in children and young adults under age 30. Females with SJS are twice as likely as males to develop TENS, and have an even higher chance if taking a category of drugs known as NSAIDs, non¬ steroidal anti-inflammatory drugs. Contact the defective prescription attorneys at Robert John and Associates if you questions.
Yaz is a combination birth control pill containing drospirenone and ethinyl estradiol. It is marketed not only as a contraceptive pill, but as a proven treatment for premenstrual dysphoric disorder (PMDD), a condition with severe emotional and physical premenstrual symptoms. Yaz is also marketed as an effective treatment for moderate acne. However, studies indicate that Yaz poses a particular health hazard because one of its two primary ingredients, drospirenone, is a diuretic, which can cause an increase in potassium levels in the blood and lead to hyperkalemia, which causes heart rhythm disturbances that can cause blood clots leading to sudden cardiac death or pulmonary embolism or strokes. Diuretics can also cause significant problems with the gallbladder, leading to gallbladder removal. Criteria: Documented use of Yaz with a diagnosis of heart attack, stroke, pulmonary embolism or DVT. Contact the defective prescription attorneys at Robert John and Associates if you have questions.
Since 2003, more than 150,000 Zimmer NexGen Flex-Knee implants have been sold. Several different components used as part of the Zimmer NexGen Flex-Knee replacement system have been associated with increased risk of complications, including pain, swelling, loosening of component parts, and the need for follow-up/revision surgery. Several prominent surgeons want a Zimmer NexGen Flex-Since 2003, more than 150,000 Zimmer NexGen Flex-Knee implants have been sold. Several different components used as part of the Zimmer NexGen Flex-Knee replacement system have been associated with increased risk of complications, including pain, swelling, loosening of component parts, and the need for follow-up/revision surgery. Several prominent surgeons want a Zimmer NexGen Flex-Knee replacement recall to be issued. At a March 2010 conference of the American Academy of Orthopaedic Surgeons, two knee surgeons presented data suggesting that the Zimmer NexGen Flex-Knee failure rate could be as high as 9%, and that the actual number of complications that require revision surgery could be even higher. The lead author of the study, Dr. Richard Berger, described the failure rate of the Zimmer NexGen CR-Flex Porous Femoral Component as "unacceptably high."
The defective medical device attorneys at Robert John and Associates would like to review any cases involving individuals who have had a Zimmer NexGen Flex-Knee device implanted, or individuals unsure of the type of knee device implanted, if that individual has had revision surgery.
The FDA has issued an updated safety communication warning doctors and patients that the placement of the surgical mesh through the vagina to treat pelvic organ prolapse may present greater risk for the patient than other options. This equipment is also called trans-vaginal mesh. According to the FDA, reported complications from using the mesh include the mesh becoming exposed or protruding out of the vaginal tissue, pain, infection, organ perforation, and urinary problems. Contact the injury lawyers at Robert John and Associates if you're experiencing any of these complications.
The FDA has approved updated warning labels for Actos, a prescription medication used to treat Type 2 diabetes. The updated label states that Actos usage for more than one year may cause bladder cancer. Actos, manufactured by Takeda, has been under FDA review since September 2010. In June 2011, the FDA issued a warning for Actos, while at the same time, drug regulators in France and Germany suspended use of the drug. The injury attorneys of Robert John and Associates are currently investigating claims involving usage of Actos, Actoplus Met, Actoplus Met XR, Duetact and bladder cancer.
A statin drug to treat high cholesterol, Lipitor was approved by the FDA in 1996 and is one of the best-selling prescription medications in the world. Recent studies have shown a possible link between Lipitor and the risk of developing Type 2 diabetes. A University of Massachusetts study found a potential link in postmenopausal women, particularly those who had a Body Mass Index (BMI) less than 25. Of the 153,840 women evaluated, more than 10,000 had developed Type 2 diabetes by the end of the study. Contact the attorneys at Robert John and Associates if you have experienced the same results.
As many as 10,000 cases of ovarian cancer diagnosed each year may have been caused by regular use of talcum powder. Talc is a mineral made of various elements including magnesium, silicon and oxygen. Talc is ground to make talcum powder which is used to absorb moisture and is widely available in various products including baby powder and adult products including body and facial powder. Talc products used regularly in the genital area could increase the risk of ovarian cancer if the powder were to travel through the vagina, uterus and Fallopian tubes to the ovaries. A jury recently found consumer health products manufacturer Johnson & Johnson knew of the cancer risks associated with its talc products but failed to warn consumers. Contact the lawyers at Robert John and Associates if you wish to know more.
(TRT) products for men have been linked to an increased risk of death, heart attack, and stroke. Researchers found men who used testosterone therapy were 30% more likely to have a heart attack, stroke, or die after three years of use. Furthermore, men who started the study with clear, unobstructed coronary arteries were just as likely to have a heart attack, stroke, or die as men who have entered the study with established coronary artery disease. Testosterone therapy, such as the prescription topical treatments Androgel, Testim, and Axiron, are used to help boost testosterone levels in men who have a deficiency of the male hormone. Contact the defective prescription drug attorneys if you are experiencing any of the complications associated with these drugs.
Paxil (paroxetine) is an antidepressant manufactured by GlaxoSmithKline. Recently, Public Health Advisories have been issued for Paxil regarding an increased risk of birth defects, persistent pulmonary hypertension (PPHN), omphalocele (an abnormality in newborns in which the infant's intestine or other abdominal organs protrude from the navel), or craniosynostosis (connections between sutures-skull bones prematurely close during the first year of life, which causes an abnormally shaped skull) in children born to mothers exposed to Paxil. We are also looking into other antidepressants known as selective serotonin reuptake inhibitors, or SSRIs, which include the brand-name drugs Zoloft, Lexapro, and Prozac, which also are linked to birth defects including heart and lung defects. If you are experiencing these symptoms, please contact the defective prescription drug lawyers at Robert John and Associates.
SSRI antidepressants such as Celexa, Lexapro, Luvox, Paxil, and Zoloft are prescribed to treat depression. Studies of the last several years have shown an increased risk of heart birth defects in children born to mothers who took SSRI antidepressants in the first trimester. Most of the cardiac defects observed in these studies are atrial or ventricular septal defects, conditions in which the wall between the right and left side of the heart does not completely develop. The pharmaceutical attorneys at Robert John and Associates are currently investigating claims of birth defects involving children whose mother was taking an SSRI, Wellbutrin or Effoxor during pregnancy.
Mirena is an IUD that was originally approved by the FDA as an intrauterine contraceptive. It was later approved as a treatment for heavy menstrual bleeding. It works by slowly releasing a low dose of levonorgestrel (a synthetic progestin hormone) directly into the uterus. Serious adverse side effects and potentially life-threatening complications have been reported following the implantation of the device. These complications include organ perforation, migration of the IUD to outside the uterus, expulsion of the IUD, and embedment in the uterus, among others. If you have concerns about this implantation device, contact the defective medical device attorneys of Robert John and Associates.
Byetta and Januvia are two drugs used to treat Type 2 Diabetes. The FDA approved Byetta in 2005 and Januvia in 2006. These drugs have been prescribed to millions of people in the United States. Since approving the medications, the FDA has issued several warnings about links between Byetta and Januvia to complications related to pancreatic diseases. Recent studies have linked these two drugs to acute pancreatitis and pancreatic cancer. We are currently investigating claims of acute pancreatitis, thyroid cancer and pancreatic cancer. Questions regarding these medications can be directed to pharmaceutical lawyers at Robert John and Associates via email or phone.
Risperdal, an atypical antipyschotic drug used to treat schizophrenia and certain problems caused by bipolar disorder, has been linked to the development of gynecomastia in boys and young men. Gynecomastia is a condition that causes boys to grow breasts. The drug is manufactured by Johnson & Johnson. If you are experiencing these symptoms, please contact the injury attorneys at Robert John and Associates today.
Fosamax (alendronate sodium), manufactured by Merck, is in a class of drugs called bisphosphonates. Fosamax ® is commonly used in tablet form to prevent and treat osteoporosis in post-menopausal women. Recently the Journal of Oral and Maxillofacial Surgeons reported a link between bisphosphonates and a serious bone disease called Osteonecrosis of the Jaw (ONJ). Osteonecrosis is a disfiguring and disabling condition of the jaw bone that causes infection and rotting of the jaw bone. Typical presentation of Osteonecrosis is pain, soft-tissue swelling and infection, loosening of teeth, drainage, and exposed bone. Symptoms may occur spontaneously, or at the site of previous tooth extraction. Recently, Fosamax has been linked to low-energy femur fractures in people taking Fosamax for three or more years.
Femur Fracture Criteria: Documented use of Fosam ® for three years or longer with diagnosed low energy femur fractures.
If you are experiencing these symptoms, please contact the injury attorneys at Robert John and Associates today.
Reglan is used to treat gastrointestinal disorders such as heartburn caused by reflux. The FDA recently required a black box warning linking Reglan and Tardive Dyskinesia. Symptoms of Tardive Dyskinesia include involuntary and repetitive movements like tongue thrusting, eye blinking and head jerking as well as involuntary movement of the fingers. These symptoms are rarely reversible with no known treatment. Those at increased risk for developing Tardive Dyskinesia are the elderly, especially older women, and people who have taken the drug for a long period of time. The FDA has advised physicians to avoid long-term use of Reglan and recommends treatment not exceed three months. Reglan is available in formulations including tablets, syrups and injections.
Criteria: Documented use of Reglan with a diagnosis or symptoms of Tardive Dyskinesia.
If you are experiencing these symptoms, please contact the injury attorneys at Robert John and Associates today.
GranuFlo and NaturaLyte are products used in the dialysis process. On June 27, 2012, the FDA issued a Class 1 recall of GranuFlo and NaturaLyte. A Class 1 recall is the most serious FDA recall, reserved for situations in which the FDA deems "there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death." Use of these dialysis products has been linked to an increased risk of cardiopulmonary arrest and sudden cardiac death. The manufacturer, Fresenius Medical Care, was aware of the dangers and injuries associated with these products but failed to warn patients and doctors until 2012. Questions regarding GranuFlo or NaturaLyte can be directed to the injury attorneys at Robert John and Associates via email or phone.
Pain pumps are portable and often disposable pain management devices which continuously administer local anesthetic through a catheter to a surgical wound site for several days following surgery to decrease post-operative pain and assist in earlier rehabilitation. A "Y-connector" accessory is sometimes available so that the pain pump can be used on multiple wound sites. Examples of pain pump manufacturers include Stryker, I-Flow, CME McKinley, Breg, Medical Flow Systems, Baxter, and Sgarlato Labs.
Recently, the use of pain pumps to administer medication directly into the glenohumeral joint space following shoulder surgery has been linked to a severe condition called Postarthroscopic Glenohumeral Chondrolysis ("Chondrolysis"), in which the cartilage of the humeral head and the glenoid space of the shoulder process has been destroyed and lost. The destruction of the shoulder cartilage can be attributed to the application of anesthetic medication directly into the joint space via the pain pump catheter. In 2003, it appears that some pain pump manufacturers may have increased the anesthetic dosing capacity of their pain pumps, which may have hastened the onset of Chondrolysis in some patients.
Chondrolysis symptoms usually present between six weeks and six months following surgery and include increased shoulder pain and stiffness, loss of cartilage, decreased range of motion, loss of shoulder joint space, crepitus in the shoulder, and loss of strength. Patients suffering from Chondrolysis are usually unable to complete their post-surgical physical therapy due to pain. Whatever the patient's condition was prior to his or her shoulder surgery, the post-operative diagnosis of Chondrolysis is typically much worse. Ultimately, complete shoulder replacement surgery (acromioarthroplasty) could become necessary in order to eliminate the painful and debilitating symptoms of Chondrolysis. If you are experiencing these symptoms, please contact the injury attorneys at Robert John and Associates today.
Metal-on-metal hip replacement manufacturers have been under heavy scrutiny over the past few years regarding the dangers of their metal on metal hip devices. The main hip devices under scrutiny are:
• Johnson & Johnson/DePuy; ASR Total Hip Replacement and ASR Resurfacing System hip
• Johnson & Johnson/DePuy: Pinnacle metal-on-metal hip;
• Zimmer: Durom Cup hip;
• Stryker: Rejuvenate and ABG II Stems (Recalled on July 4, 2012);
• Biomet: M2a and 38 Diameter hips;
• Wright: (a) Conserve, (b) Dynasty, (c) Lineage and (d) rofemur (femur fracture) hips; and
• Smith and Nephew: R3 Liner hips (Recalled on June 1, 2012).
Metal-on-metal hip patients from the above manufacturers have similarly reported problems after their initial implant surgery resulting in revision surgery. All have reported a variety of symptoms, including pain, swelling and problems walking. These symptoms are normal for patients following a hip replacement, but can be a sign that something is wrong if they continue or come back frequently. Additionally, metal debris spreading in the hip area has been reported due to the metal-on-metal friction involved from the metal components moving together.
We would like to review any cases involving individuals who have had any of the above metal-on-metal hip devices implanted and all individuals unsure of the type of hip device implanted if the person has had revision surgery, or the person is experiencing hip pain, hip swelling or difficulty walking. If you are experiencing these symptoms, please contact the injury attorneys at Robert John and Associates today.